SCHEMBL9703964

SCHEMBL9703964

CCn1c(=O)c(C(=O)O)nc2cc3ccccc3cc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.58
CASP1 P29466 1/20 0.58
CASP7 P55210 1/20 0.58
ALDH1A1 P00352 9/20 0.47
MAPT P10636 5/20 0.46
TP53 P04637 1/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46
CYP2D6 P10635 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
HTT P42858 3/20 0.45
CYP3A4 P08684 1/20 0.45
PPARG P37231 1/20 0.45
KDM4E B2RXH2 5/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9704918 0.82 MAPK1 (0.50) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL9703578 0.81 MAPK1 (0.49) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL9705722 0.81 MAPK1 (0.49) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL6606816 0.80 NLRP3 (0.59) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL9704330 0.77 MAPK1 (0.45) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL9703943 0.75 CYP1A2 (0.52) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL8861179 0.74 ALDH1A1 (0.70) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL9103612 0.71 MAPK1 (0.62) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL6080442 0.71 MAPK1 (0.51) MAPK1CASP1CASP7ALDH1A1MAPT
SCHEMBL9107325 0.71 MAPK1 (0.61) MAPK1CASP1CASP7ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992011245-A1 2-ACYLAMIDO DERIVATIVES OF 3,4-DIHYDRO-3-OXO-QUINOXALINE HAVING PHARMACEUTICAL ACTIVITY WARNER-LAMBERT COMPANY (US) 1992-07-09 WO disclosed